No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / adverse effects
-
Adrenergic beta-Antagonists / therapeutic use
-
Alprostadil / adverse effects
-
Alprostadil / therapeutic use
-
Apomorphine / adverse effects
-
Apomorphine / therapeutic use
-
Dopamine Agonists / adverse effects
-
Dopamine Agonists / therapeutic use
-
Female
-
Humans
-
Phentolamine / adverse effects
-
Phentolamine / therapeutic use
-
Phosphodiesterase Inhibitors / adverse effects
-
Phosphodiesterase Inhibitors / therapeutic use
-
Sexual Dysfunction, Physiological / drug therapy*
-
Sexual Dysfunctions, Psychological / drug therapy*
-
Vasodilator Agents / adverse effects
-
Vasodilator Agents / therapeutic use
Substances
-
Adrenergic beta-Antagonists
-
Dopamine Agonists
-
Phosphodiesterase Inhibitors
-
Vasodilator Agents
-
Alprostadil
-
Apomorphine
-
Phentolamine